Evidence map›Paper›PMID 41860988›Full record

ArticlePloS one2026

Visual analytics framework for survival analysis and biomarker discovery from gene expression data.

Jaka Kokošar, Cagatay Turkay, Luka Ausec, Miha Štajdohar, Blaž Zupan

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jaka KokošarFaculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia.
Cagatay TurkayCentre for Interdisciplinary Methodologies, University of Warwick, Coventry, United Kingdom.ORCID https://orcid.org/0000-0001-6788-251X
Luka AusecGenialis Inc., Boston, Massachusetts, United States of America.
Miha ŠtajdoharGenialis Inc., Boston, Massachusetts, United States of America.
Blaž ZupanFaculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-5864-7056

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We introduce a visual analytics methodology for survival analysis, and propose a framework that defines a reusable set of visualization and modeling components to support exploratory and hypothesis-driven biomarker discovery. Survival analysis-essential in biomedicine-evaluates patients' survival rates and the onset of medically relevant events, given their clinical and genetic profiles and genetic predispositions. Existing approaches often require programming expertise or rely on inflexible analysis pipelines, limiting their usability among biomedical researchers. The lack of advanced, user-friendly tools hinders problem solving, limits accessibility for biomedical researchers, and restricts interactive data exploration. Our methodology emphasizes functionality-driven design and modularity, akin to combining LEGO bricks to build tailored visual workflows. We (1) define a minimal set of reusable visualization and modeling components that support common survival analysis tasks, (2) implement interactive visualizations for discovering survival cohorts and their characteristic features, and (3) demonstrate integration within an existing visual analytics platform. We implemented the methodology as an open-source add-on to Orange Data Mining and validated it through use cases ranging from Kaplan-Meier estimation to biomarker discovery. While the framework is generally applicable, we illustrate its value through case studies in cancer research, where survival analysis is of critical importance. The resulting framework illustrates how methodological design can drive intuitive, transparent, and effective survival analysis.

Indexed as

BiomarkersGene Expression ProfilingData AnalyticsData MiningHumansKaplan-Meier EstimateSurvival AnalysisBiomarkers

Identifiers

PMID41860988
PMCPMC13004513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.